Professional Documents
Culture Documents
information@lymphomas.org.uk
www.lymphomas.org.uk
What is thrombocytopenia?
Thrombocytopenia is a shortage of platelets. If you dont have a normal number of platelets,
doctors say that you are thrombocytopenic.
Platelets are made in the bone marrow (the spongy centre of some bones). They develop
from huge cells in the bone marrow called megakaryocytes. Usually platelets stay in the
bloodstream for about 10 days before they are removed by the spleen. The bone marrow
works all the time to make new platelets. It works harder if platelets are needed to stop
bleeding somewhere in your body.
We have more information about blood tests and the full blood count, which you can read on
our website at www.lymphomas.org.uk. You can also print this information at home or ask
our helpline to send you a copy. Please email us at information@lymphomas.org.uk or call
on 0808 808 5555.
If you have a low number of platelets, it is harder for you to form a blood clot. This means you
may bleed for longer if you cut yourself. You may also bruise more easily than normal.
If lymphoma cells are in the bone marrow, they take up space that is normally used to
produce healthy blood cells. This can lower the number of platelets your bone marrow makes,
meaning you have fewer platelets and become thrombocytopenic.
This type of thrombocytopenia often begins to improve once treatment for the lymphoma has
started to work.
Although the aim of chemotherapy is to kill the lymphoma cells, a side effect of many types of
chemotherapy is the destruction of some healthy cells. This can affect the megakaryocytes in
the bone marrow that would normally make new platelets. If the number of new platelets
made doesnt meet the number needed in the bloodstream, the platelet count falls.
If it is going to occur, thrombocytopenia usually starts about 610 days after the start of
chemotherapy. Not all treatments result in thrombocytopenia. How low your platelet levels go
after treatment and for how long depends on:
Some of the newer targeted therapies can cause thrombocytopenia and increase the risk of
bleeding. Ibrutinib (Imbruvica) may cause bleeding because of its effect on the way platelets
work, without affecting their number. Because of this, it isnt usually given to people who are
taking drugs to thin the blood, such as warfarin. Bortezomib (Velcade),
obinutuzumab (Gazyvaro) and lenalidomide (Revlimid) can also cause low platelet levels.
Radiotherapy doesnt normally have much of an effect on the bone marrow. It doesnt usually
cause low platelet levels on its own.
We have more information about types of treatment for lymphoma, which you can read on our
website at www.lymphomas.org.uk. You can also print this information at home or, if you
prefer, our helpline can send you copies. Please email at information@lymphomas.org.uk
or call on 0808 808 5555.
Splenomegaly
As well as being found in the blood, some of the bodys platelets are always found in the
spleen. If the spleen is bigger than normal (splenomegaly), there is space in it for more
platelets. As a result, the platelets tend to collect in the spleen, leaving fewer than normal in
the bloodstream.
Treatments that shrink the spleen may help if this is the cause of your thrombocytopenia.
Sometimes the spleen is removed (splenectomy). This may be done to treat the lymphoma
but usually helps improve platelet levels too.
Sometimes the bodys immune system starts to make antibodies against cells within the body.
These antibodies are known as autoantibodies.
If the autoantibodies stick to platelets, these platelets are removed when they pass through
the spleen. When the bone marrow cant make new platelets fast enough to replace the ones
lost, thrombocytopenia develops. This type of thrombocytopenia is known as immune
thrombocytopenic purpura (ITP). It happens more often in people with low-grade lymphomas,
such as chronic lymphocytic leukaemia (CLL).
We have more information about the lymphatic and immune systems, which you can read on
our website at www.lymphomas.org.uk. You can also print this information at home or, if you
prefer, our helpline can send you copies. Please email at information@lymphomas.org.uk
or call on 0808 808 5555.
having another problem with blood clotting, for example, lymphoma in the liver might
mean fewer clotting factors are made
being on other drugs that affect blood clotting, such as aspirin, heparin or warfarin
having a fever (high temperature) as this tends to use up platelets faster and make
bleeding worse.
If your platelet count falls to very low levels, symptoms become more likely. A general guide to
what you might expect with different numbers of platelets is:
nosebleeds
mouth or gum bleeding
heavy periods in women
blood in urine
bleeding from the bowel this can be obvious blood or may make your stools black
in colour.
As well as bruising more easily, you may also notice purpura (petechia). These are small red
or purple spots on the skin (often on the legs) or on the lips or in the mouth. They can appear
temporarily when platelets are very low.
The key to avoiding serious problems caused by low platelets is to get in touch with your
hospital quickly if you start bleeding.
Platelet transfusions dont work well for immune thrombocytopenic purpura (ITP). Instead,
treatment for ITP aims to lower the levels of the autoantibody.
There are drugs that boost the megakaryocytes to make more platelets (thrombopoietin
receptor agonists). These are similar to the growth factors G-CSF (used to raise the white
blood cell count) and erythropoietin (used to treat anaemia). They are sometimes used to treat
ITP. At present, they are not used to treat thrombocytopenia that is caused by chemotherapy.
If you are on warfarin, heparin or aspirin and develop bleeding, you might need to stop taking
the blood thinner or lower its dose. This might also be done if your platelets are low, especially
if you have liver problems too. Your medical team will tell you if you need to make changes;
always check with them before you stop, start, or change the dose of your drugs.
Occasionally, other treatments to help your blood clot, such as vitamin K or an infusion of
fresh frozen plasma (FFP), might be needed.
Platelet transfusion
If you are bleeding and your platelets are low, you may be given a platelet transfusion. This is
similar to a blood transfusion given for anaemia, except it takes only about half an hour.
Platelet transfusions are as safe as other blood transfusions.
The platelets that are given do not make the platelet count normal again. Instead, they stop
any bleeding thats already occurred or lower the risk of further loss of blood. Because the
platelets get used up, the effect only lasts for a few days.
people who are actively bleeding and have a low platelet count
people who have an extremely low platelet count, which makes them likely to bleed
people who have a low platelet count and need to have an operation or another
significant medical procedure.
Once your platelets are no longer being destroyed, the dose of steroid is lowered.
Treating your lymphoma may also help to stop the autoantibodies being made. Rituximab
(MabThera), with or without chemotherapy, tends to reduce the number of autoantibodies as
well as kill the lymphoma cells.
We have more information about steroids and rituximab, which you can read on our website at
www.lymphomas.org.uk. You can also print this information at home or, if you prefer, our
helpline can send you copies. Please email at information@lymphomas.org.uk or call on 0808
808 5555.
avoid high-impact sports (eg long-distance running) and contact sports (eg rugby)
wear gloves, long sleeves and long trousers to help protect you from scratches and cuts
when gardening or doing DIY
take extra care to avoid cutting yourself when using knives to prepare food
avoid blowing your nose too hard or too often
use an electric razor over wet shaving
brush your teeth regularly but gently using a soft-bristled toothbrush (eg a
childs toothbrush)
avoid flossing your teeth if it causes bleeding.
info@itpsupport.org.uk
www.itpsupport.org.uk
Sources used
These are a few of the sources we used to prepare this information. The full list of sources is
available on request. Please contact us by email at publications@lymphomas.org.uk or
phone on 01296 619409 if you would like a copy.
Norfolk D (ed). Handbook of Transfusion Medicine. 5th edition. 2013. The Stationery
Office, Norwich.
Crighton GL, et al. A therapeutic-only versus prophylactic platelet transfusion strategy for
preventing bleeding in patients with haematological disorders after myelosuppressive
chemotherapy or stem cell transplantation. Cochrane Database of Systematic Reviews, 2015.
9: Cd010981.
Acknowledgements
With thanks to Dr Paul Revell, member of our Medical Advisory Panel and formerly Consultant
Haematologist at Stafford Hospital, for reviewing this information.
We would also like to thank the members of our Reader Panel who gave their time to review
this information.
The images used in this information are provided by Science Photo Library.
LYMweb0055/Thrombo/2016v3
We continually strive to improve our resources for people affected by lymphoma and we
would be interested in any feedback you might have about this information. Please
visit www.lymphomas.org.uk/feedback or email publications@lymphomas.org.uk if you have
any comments. Alternatively please phone our helpline on 0808 808 5555.
If you have found this information useful and would like to help make it available to other
people coping with lymphoma, then please consider making a donation to support our work
at www.lymphomas.org.uk/donate. We rely totally on voluntary donations. Thank you.
Disclaimer
We make every effort to make sure that the information we provide is accurate but it should not be relied upon to reflect the current state of medical research, which is
constantly changing. If you are concerned about your health, you should consult your doctor. The Lymphoma Association cannot accept liability for any loss or damage
resulting from any inaccuracy in this information or third party information such as information on websites we link to.
The following user-generated information is excluded from the scope of our Information Standard certification: weblogs, chatroom, forums and personal experience
pages. Neither The Information Standard scheme operator nor the scheme owner shall have any responsibility whatsoever for costs, losses or direct or indirect
damages or costs arising from inaccuracy of information or omissions in the information published on the website on behalf of the Lymphoma Association.